They showed that this treatment elicited an IFNγ-mediated T-cell response in all patients, among which a patient with CRC had stable disease for 7 months, and two patients (breast and renal CA) were able to achieve 3-year remission with subsequent dendritic cell immunotherapy [40]. Here, IFNG is linked to colorectal carcinoma.